您现在的位置: 首页> 研究主题> 脑缺血/药物疗法

脑缺血/药物疗法

脑缺血/药物疗法的相关文献在2000年到2020年内共计75篇,主要集中在神经病学与精神病学、药学、中国医学 等领域,其中期刊论文75篇、专利文献179384篇;相关期刊14种,包括陕西中医、医学临床研究、安徽医科大学学报等; 脑缺血/药物疗法的相关文献由252位作者贡献,包括楼敏、严慎强、张圣等。

脑缺血/药物疗法—发文量

期刊论文>

论文:75 占比:0.04%

专利文献>

论文:179384 占比:99.96%

总计:179459篇

脑缺血/药物疗法—发文趋势图

脑缺血/药物疗法

-研究学者

  • 楼敏
  • 严慎强
  • 张圣
  • 万锦平
  • 陈智才
  • 魏尔清
  • 伍期专
  • 刘克勤
  • 姚存姗
  • 娄一萍
  • 期刊论文
  • 专利文献

搜索

排序:

年份

    • 张弛; 王麒
    • 摘要: [目的]探讨补阳还五汤联合丁苯酞对缺血性脑卒中患者神经功能及预后的影响.[方法]选取2017年3月至2019年2月本院收治的110例缺血性脑卒中患者,采用随机数表法将其分为观察组和对照组,每组各55例.对照组给予丁苯酞治疗,观察组在对照组的基础上联合补阳还五汤进行治疗.观察两组患者在治疗过程中的临床疗效、神经功能、预后及不良反应的发生情况.[结果]观察组临床总有效率为92.73%(51/55),显著高于对照组的74.55%(41/55),差异有统计学意义(χ2=6.6425,P<0.05).治疗后,两组患者美国国立卫生研究院卒中量表(NIHSS)评分、改良Rankin量表(MRS)评分均显著降低,观察组明显低于对照组(P<0.05);两组斯堪的纳维亚卒中量表(SSS)评分均显著升高,观察组高于对照组(P<0.05).观察组不良反应发生率为3.64%(2/55),对照组不良反应发生率为14.54%(8/55),差异有统计学意义(P<0.05).[结论]补阳还五汤联合丁苯酞治疗缺血性脑卒中可明显改善患者神经功能,患者预后效果良好,且不良反应少,安全有效,值得在临床上推广应用.
    • 梁刚; 牛育苗; 李一涵; 魏安怡; 董静尹; 曾玲晖
    • 摘要: 目的:探讨雷帕霉素在大鼠局灶性脑缺血再灌注后24 h给药对脑损伤的保护作用.方法:104只Sprague Dawley大鼠随机分为手术对照组、模型对照组、建模后6 h雷帕霉素给药组(6 h给药组)和建模后24 h雷帕霉素给药组(24 h给药组).采用Longa法建立大鼠大脑中动脉缺血再灌注模型.采用神经功能损伤程度评分(NSS)对大鼠进行神经功能评分;氯化三苯基四氮唑(TTC)染色法检测各组大鼠脑梗死体积;Fluoro-Jade B(FJB)染色法检测大鼠脑组织神经元凋亡;蛋白质印迹法检测各组大鼠mTOR信号通路磷酸化S6蛋白表达.结果:与手术对照组比较,模型对照组大鼠NSS升高,脑梗死体积增加,FJB阳性细胞增多,半暗带磷酸化S6蛋白表达量增加(均P0.05).结论:缺血再灌注后24 h给予雷帕霉素对大鼠局灶性脑缺血再灌注所致脑损伤仍有保护作用.
    • 王建峰; 张晨红; 王婉
    • 摘要: 目的:探讨缺血性脑血管病(ICVD)危险因素及药物治疗疗效.方法:选取200例ICVD患者为观察组,采用随机数字表法抽取195例体检者为对照组,两组患者进行单因素和多因素非条件Logistic回归分析;观察组实施依达拉奉与丹红注射液联合治疗对患者神经功能损伤和生活自理能力的影响及临床疗效.结果:单因素分析显示,ICVD和高血压、腔隙性脑梗死数目、心房颤动三酰甘油(TG)、血清总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、同型半胱氨酸(Hcy)、脑白质疏松程度和颈动脉粥样斑块有相关性;Logistic回归分析表明:高血压、腔隙性脑梗死数目、Hcy和脑白质疏松程度是ICVD的独立危险因素;观察组患者治疗后NIHSS评分显著下降,治疗总有效率97.50%.结论:高血压、腔隙性脑梗死数目、Hcy和脑白质疏松程度是ICVD的独立危险因素,且依达拉奉与丹红注射液联合使用能有效改善患者神经功能损伤及生活自理能力.
    • 张斌斌; 吴美玲; 刘露娜; 竺杨彬; 开洁静; 曾玲晖
    • 摘要: 目的:探索哺乳动物雷帕霉素靶蛋白(mTOR)抑制剂雷帕霉素在慢性脑缺血中的作用及机制.方法:6 周龄的ICR 小鼠通过右颈总动脉结扎诱导慢性脑缺血模型,采用蛋白质印迹法检测造模后不同时期(1、3、6、24 h,3、7 d,2、4、6 周)小鼠大脑皮层和海马组织中mTOR 信号通路mTOR、S6K 和S6 蛋白表达及其磷酸化水平.造模24 h 后腹腔注射雷帕霉素(3.0 mg/kg),经Fluoro-Jade B 染色观察细胞凋亡情况,蛋白质印迹法检测mTOR 信号通路的变化和对细胞自噬的影响,并采用Morris 水迷宫和Y 迷宫试验测定小鼠学习记忆功能.结果:模型小鼠大脑皮层和海马组织中mTOR 信号通路被异常激活,从6 h 开始一直持续到6 周,表现为mTOR、S6K 和S6 蛋白磷酸化增加.雷帕霉素可逆转由慢性脑缺血所致的mTOR 信号通路激活,并显著减少细胞凋亡(146.1 ±16.3与84.5 ±9.6,P <0.05).雷帕霉素还能显著逆转慢性脑缺血所导致的Beclin1和LC3-Ⅱ蛋白的表达.Morris 水迷宫和Y 迷宫试验结果显示,雷帕霉素组较模型组平台潜伏期缩短[(11.1 ±2.3)s 与(8.1 ±1.8)s,P <0.05]、游泳距离延长[(672.8 ±128.5) cm 与(558.2 ±124.9) cm,P <0.05]、穿越平台次数减少(2.8 ±0.9 与5.2 ±0.8,P <0.05)、正确反应率提高[(38.5 ±9.2)%与(64.9 ±7.9)%,P <0.05].结论:抑制mTOR 信号通路能改善由慢性脑缺血所致的学习记忆功能下降,其机制可能与抑制细胞凋亡和自噬相关.%Objective: To investigate the effect of mammalian target of rapamycin (mTOR)inhibitor—rapamycin on cognitive function after chronic cerebral ischemia in mice and its molecular mechanism.Methods: The chronic cerebral ischemia model was induced by ligation of right common carotid artery(rUCCAO)in 6-week-old ICR mice.The expressions of mTOR,S6K,S6 and corresponding phosphorylated proteins were detected by Western blotting at different time interval(1 h, 3 h, 6 h, 24 h, 3 d,7 d,2 w,4 w,6 w)after rUCCAO to determine the changes of mTOR signaling pathway.Rapamycin was administrated i.p.at the dose of 3.0 mg/kg 24 h after rUCCAO.Fluoro Jade B staining was used to detect the apoptotic cells.The expressions of Beclin and LC3-Ⅱ were detected by Western blotting to determine the status of autophagy.Morris water maze test and Y maze test were performed to evaluate cognitive functions.Results: The mTOR signaling pathway was abnormally activated from 6 h to 6 w after rUCCAO in mouse cortex.The activation of mTOR signaling pathway induced by rUCCAO was reversed by administration of rapamycin, and the apoptotic cell number was significantly decreased(146.1 ±16.3 vs 84.5 ± 9.6, P<0.05).Meanwhile,the elevation of Beclin and LC3-Ⅱ protein induced by rUCCAO was reversed by rapamycin administration.Furthermore, compared with vehicle-treated mice, the latent period[(11.1 ±2.3)s vs(8.1 ±1.8)s, P <0.05]and swimming distance[(672.8 ±128.5)cm vs(558.2 ±124.9)cm,P<0.05]were significantly decreased and the number of crossing the platform quadrant in Morris water maze increased(2.8 ±0.9 vs 5.2 ±0.8, P<0.05)in rapamycin-treated mice.Correct response rate in the Y maze was also increased significantly in rapamycin-treated mice[(38.5 ±9.2)% vs(64.9 ±7.9)%, P<0.05]. Conclusion: Inhibiting mTOR pathway by rapamycin reverses the rUCCAO-induced cognitive impairment partly through the suppression of apoptosis and autophagy.
    • 林慈宽
    • 摘要: 目的:研究氯吡格雷对阿司匹林抵抗(A R )的缺血性脑血管病的影响。方法:将200例缺血性脑血管疾病阿司匹林抵抗患者随机分为对照组与观察组,每组100例。对照组患者给予阿司匹林100 m g/d口服,观察组患者在给予阿司匹林100 m g/d口服的同时给予氯吡格雷75 m g/d口服。比较两组患者4周后的血小板聚集率、阿司匹林抵抗和半抵抗发生率显著下降,以及6个月后两组患者缺血性脑血管疾病的复发率。结果:治疗4周后,两组患者的血小板聚集率均有所下降(P<0.05);观察组患者的血小板聚集率下降幅度显著大于对照组(P<0.05),且观察组阿司匹林抵抗和半抵抗发生率显著低于对照组(P<0.05)。6个月后,观察组患者复发率显著低于对照组(P<0.05)。结论:对于缺血性脑血管病阿司匹林抵患者,使用氯吡格雷和阿司匹林联合治疗,可显著降低患者血小板聚集率、AR和半AR发生率以及降低患者复发率。
    • 罗何婷; 张金培; 薛常虎; 杨海霞
    • 摘要: 目的:探讨舒血宁注射液治疗老年缺血性脑血管病临床疗效。方法:100例老年脑梗死患者作为研究对象,随机分为两组,即对照组和观察组,对照组患者给予常规治疗,观察组患者在常规治疗基础上给予舒血宁注射液。治疗后,比较两组患者的血液流变学各项指标变化以及临床疗效。结果:两组患者在治疗前后血液流变学各指标均有显著改善,且观察组患者红细胞聚集指数、全血粘度、红细胞变形指数以及血浆粘度等指标下降显著好于对照组,差异有统计学意义(P<0.05)。对照组和观察组患者在治疗后总有效率分别为74%和94%,观察组临床疗效显著好于对照组,差异具有统计学意义( P<0.05)。结论:舒血宁注射液用于治疗老年脑梗死患者,可以显著提高患者血液流变学各项指标,临床疗效显著,无不良反应,具有临床推广价值。
    • 曹天然; 刘青芳
    • 摘要: [Objective]To explore the effects of Danhong injection on the brain tissue expression of glial fibril‐lary acidic protein (GFAP) after cerebral ischemic reperfusion (IR) in rats .[Methods]A cerebral ischemia‐reperfu‐sion rat model was established through an occlusion of middle cerebral artery .A total of 96 healthy male Sprague‐Dawley rats were randomly divided into 4 groups of normal control ( n =8) ,sham operation ( n =8) ,ischemia reperfusion ( n =40) and Danhong injection ( n=40) .The expressions of GFAP in brain tissue were detected by immunohistochemistry at 6h ,24h ,48h ,72h and 7d post‐IR in ischemia‐reperfusion and Danhong intervention groups .Before sacrificing ,the neurological deficit scores were evaluated for all rats .The experimental results were analyzed with Spss17 .0 .[Results]The expressions of GFAP were weak in both normal control and sham op‐eration groups .And the levels of GFAP were evidently up‐regulated at 6h and peaked at 72h ( P <0 .05) .Then there was a gradual decline .Compared with ischemia/reperfusion group ,the levels of GFAP evidently decreased in Danhong intervention group ( P<0 .05) .At 24h ,48h ,72h and 7d ,the neurological deficit score of Danhong in‐tervention group was better than that of ischemia/reperfusion group .And the neurological deficit scores decreased in Danhong group ( P<0 .05) .[Conclusion]After ischemia‐reperfusion injury ,the levels of GFAP were evidently up‐regulated in ischemia‐reperfusion rats .Injury of brain tissue after ischemia‐reperfusion is blunted in Danhong intervention group .And Danhong may down‐regulate the level of GFAP and suppress the excessive proliferation of astrocytes .%目的探讨脑缺血再灌注损伤(I/R)大鼠丹红注射液干预后胶质原纤维酸性蛋白(GFAP)的表达变化。方法96只SD大鼠随机分为:正常对照8只(N组),不做任何处理;假手术组8只(S组),仅分离出血管,不做其他处理;缺血再灌注损伤组40只(I/R组),丹红注射液干预组40只(DI/R组),两组均采用大脑中动脉闭塞方法制作大鼠脑缺血再灌注模型。模型成功后,DI/R组从实验前一天开始腹腔注射丹红注射液(8 mL/kg ,Qd);I/R组在相同时间点注射生理盐水。并于再灌注后6h、24h、48h、72h、7d的各时间点分批处死动物,免疫组织化学方法检测各组大鼠脑内GFAP的表达情况;各组大鼠在处死前行神经功能缺损评分。结果 N组和S组神经细胞中GFAP阳性细胞较少;I/R组缺血再灌注6 h GFAP的表达开始增加,72 h GFAP表达增加达到高峰,缺血再灌注7 d表达减少,DI/R组GFAP表达趋势同缺血再灌注组,但各时间点阳性细胞数明显低于I/R组( P <0.05);除6 h外的其余各时间点,DI/R组大鼠神经功能缺损均小于I/R组( P <0.05),且DI/R组缺血再灌注时间越长,神经功能缺损程度越轻( P<0.05)。结论大鼠脑缺血再灌注损伤后,GFAP的表达上调,但丹红注射液下调GFAP的表达,抑制星形胶质细胞过度增生,减轻脑缺血后损伤。
    • 严晓波; 张圣; 严慎强; 楼敏
    • 摘要: 目的:观察不同严重程度急性缺血性卒中(AIS)患者静脉溶栓远期预后和出血转化的影响因素。方法:回顾性分析2009年6月至2013年12月在浙江大学医学院附属第二医院神经内科因AIS接受静脉溶栓治疗患者的资料,根据美国国立卫生研究院卒中量表(NIHSS)将患者分为轻度(≤8分)、中度(9~15分)、重度(≥16分)三组,分别观察影响患者溶栓后的预后(3月时改良Rankin评分≤2分定义为预后良好)及发生出血转化的因素。结果:共365例患者纳入分析:轻度134例、中度121例、重度110例。轻度AIS患者中,年龄[ OR=0.937,95%可信区间(CI):0.898~0.978;P=0.003]、基线NIHSS(OR=0.732,95%CI:0.564~0.950;P=0.019)、发病至治疗时间在270 min内( OR=4.109,95%CI:1.441~11.719;P=0.008)是预后良好的独立影响因素;而基线血糖( OR=1.326,95%CI:1.009~1.743;P=0.043)是发生脑实质出血型出血转化的独立影响因素。中度AIS患者中,年龄( OR=0.954,95%CI:0.924~0.984;P=0.003)、基线NIHSS ( OR=0.760,95%CI:0.619~0.933;P=0.009)是预后良好的独立影响因素;而心房颤动( OR=3.307,95%CI:1.140~9.596;P=0.028)、收缩压( OR=0.967, 95%CI:0.943~0.991;P=0.008)是发生出血性梗死型出血转化的独立影响因素,心房颤动( OR=36.972,95%CI:1.770~772.462;P=0.02)是发生脑实质出血型出血转化的独立影响因素。重度AIS患者中,基线NIHSS ( OR=0.808,95%CI:0.677~0.963;P=0.018)是预后良好的独立影响因素,未发现发生溶栓后出血转化的独立影响因素。结论:对于不同严重程度的AIS患者,影响静脉溶栓后远期预后及发生出血转化的影响因素不尽相同;发病至治疗时间在270 min内是轻度AIS患者静脉溶栓后3个月预后良好的独立影响因素;心房颤动是中度AIS患者静脉溶栓后发生出血转化的独立影响因素。%Objective: To investigate the factors related to therapeutic outcomes of intravenous thrombolysis in patients with acute ischemic stroke ( AIS ) of different severity. Methods: Clinical data of patients with AIS treated with intravenous thrombolysis in the Second Affiliated Hospital , Zhejiang University School of Medicine between June 2009 and December 2013 were retrospectively reviewed .According to National Institutes of Health Stroke Scale ( NIHSS ) , patients were categorized as mild stroke (≤8 , n=134 ) , moderate stroke ( 9-15 , n=121 ) and severe stroke (≥16 , n=110 ) .The good outcome was defined as modified Rankin Scale ≤2 .The factors related to functional outcomes and hemorrhagic transformation ( HT) were analyzed and compared among 3 groups.Results:Among 365 enrolled patients , good outcomes in 3 groups were 78 .4% ( 105/134 ) , 47 .9% ( 58/121 ) and 24 .5%( 27/110 ) , respectively.In patients with mild stroke, age (OR=0.937, 95%CI:0.898-0.978;P=0.003), baseline NIHSS (OR=0.732, 95%CI:0.564 -0.950; P =0.019), onset to needle time (ONT) within 270 min (OR=4.109, 95%CI:1.441-11.719;P=0.008 ) independently predicted good outcome , while baseline glucose ( OR =1.326, 95%CI:1.009 -1.743; P =0.043 ) was independently associated with parenchymal hematoma ( PH ) .In patients with moderate stroke , age ( OR =0 .954 , 95%CI: 0.924 -0.984; P =0.003) and baseline NIHSS (OR =0.760, 95%CI:0 .619 -0 .933; P =0 .009 ) independently predicted good outcome , while atrial fibrillation ( OR=3 .307 , 95%CI:1 .140~9 .596; P=0 .028 ) and systolic pressure ( OR=0.967, 95%CI:0.943~0.991;P=0.008) was independently associated with hemorrhagic infaction .Atrial fibrillation ( OR=36 .972 , 95%CI:1 .770-772 .462;P=0 .02 ) was independently associated with PH . In patients with severe stroke , baseline NIHSS (OR=0.808, 95%CI:0.677 -0.963; P =0.018) independently predicted good outcome , while no independent risk factors of HT was found . Conclusion:For different severity of AIS patients , the related factors of functional outcome and HT after thrombolysis were different .
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号